Endocardial Fibrotic Lesions Have a Greater Effect on Peak Longitudinal Strain than Epicardial Fibrotic Lesions in Hypertrophic Cardiomyopathy Patients

  • Funabashi Nobusada
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine
  • Takaoka Hiroyuki
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine
  • Ozawa Koya
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine
  • Kobayashi Yoshio
    Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine

この論文をさがす

抄録

<p>Peak longitudinal strain (PLS) of the left ventricular (LV) myocardium by transthoracic echocardiogram (TTE) is useful to detect LV myocardial damage. We hypothesized that myocardial fibrosis (MF) in the LV myocardium may influence PLS. Eighteen hypertrophic cardiomyopathy (HCM) patients (14 males; 58 ± 17 years old) underwent 1.5 Tesla cardiac magnetic resonance (CMR) and TTE. Patients with previous myocardial infarction were excluded. We used TTE to assess whole-layer PLS in an American Heart Association-defined 17-segment LV model. Whole-layer PLS was calculated using Echo PAC, version 113 (GE Healthcare). MF was assessed by T1-weighted CMR of the LV endocardial layer, the LV epicardial layer, or both the LV endocardial and epicardial layers for each lesion. Of the 306 segments, MF was detected in the LV endocardial layer only (13 segments), in the LV epicardial layer only (9 segments), or in both LV endocardial and epicardial layers (59 segments). PLS values were significantly lower in segments with MF affecting only the LV endocardial layer (7% ± 4%) (P < 0.05) and where MF was observed in both the LV endocardial and epicardial layers (9% ± 5%) (P = 0.001) compared with segments without MF (13% ± 7%). No significant difference in PLS values was detected between the MF segments for the LV epicardial layer only (10% ± 6%) and those without MF (13% ± 7%) (P > 0.05). In HCM patients, fibrotic lesions in the LV endocardium have a greater adverse effect on PLS than those in the LV epicardium. Our results are significant for HCM patients with fibrotic lesions within the LV endocardium.</p>

収録刊行物

  • International Heart Journal

    International Heart Journal 59 (2), 347-353, 2018

    一般社団法人 インターナショナル・ハート・ジャーナル刊行会

被引用文献 (3)*注記

もっと見る

参考文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ